Epigenica AB, the biotech firm behind cutting-edge epigenetic analysis tools, is bringing its flagship EpiFinder platform to Japan through a new distribution deal with PrimeTech Co, a leading life sciences distributor.

 

The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits, supporting research in genomics, biomarker discovery, and translational medicine.

 

"Japan is a highly innovative market with world leading research institutions and strong interest in advanced omics technologies," said Mohamad Takwa, CEO and co-founder of Epigenica. "We are delighted to partner with PrimeTech to make EpiFinder more accessible to researchers in Japan and support new discoveries in areas such as cancer biology, aging research, and precision medicine."

 

PrimeTech, known for introducing innovative life science tools to Japanese laboratories, will distribute EpiFinder kits and assist local researchers in adopting the platform.

 

"We are very pleased to collaborate with Epigenica and introduce the EpiFinder technology to researchers in Japan," said Ryosuke Ogihara, CEO of PrimeTech. "The ability to generate epigenetic information at the scale that EpiFinder offers opens exciting opportunities for biomarker discovery and translational research."